-=6 HEADLINES

Indian Market

Indian equity markets were down 0.13%

Nifty down by 7.40 pts and settle at 5651.35

Sensex down by 57.27 pts at 18735.60

Bank Nifty down by 34.30 pts at 11204.05

Global Market

European markets were down with FTSE down by 4.18 closed at 6384 ,CAC down by 19.69 closed at 3755 and DAX down by 24.10 closed at 7908.

Dow future was up 11.00 closed at

14358.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY NEWSLETTER

25 TH MARCH 2013

HEADLINES

• To resume operations in Andhra, may

recover Rs 300cr: SKS

• Dish TV to increase pack prices, stock

gains 3%

• Hike in excise duty could hurt UV sales

• Mallya to submit Kingfisher Airline's

revival plan next week

FII’s and DII’s

CATEGORY DATE BUY SELL NET

FII 22-Mar-13 2931.55 2945.75 -14.2

DII 22-Mar-13 1053.27 1188.84 -135.57

NIFTY DAILY PIVOTS

PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 5837 5777 5717 5684 5657 5624 5597 5537 5477

WWW.EPICRESEARCH.CO 09752199966

MARKET ANALYSIS:

Immense volatility was witnessed on the bourses in late trade as key benchmark indices once again

slipped into the red soon after moving into positive zone from negative zone. The barometer index, the

S&P BSE Sensex, was provisionally down 55.12 points or 0.29%, off 122.07 points from the day's

high and up 68.55 points from the day's low. The market breadth was weak. The BSE Small-Cap index

was off almost 1%. Index heavyweight Reliance Industries (RIL) edged lower in volatile trade.

Another index heavyweight and cigarette major ITC edged higher in choppy trade.

Realty stocks extended recent losses. IT stocks edged lower as Oracle Corp's third quarter revenue fell

short of analysts' expectations.

The market edged higher in early trade on firm Asian stocks. Key benchmark indices reversed initial

gains and hit their lowest level in almost 2-1/2 weeks in morning trade. Volatility ruled the roost as key

benchmark indices regained positive zone in mid-morning trade. Key benchmark indices held firm in

early afternoon trade. The Sensex extended gains to hit fresh intraday high in afternoon trade.

Volatility ruled the roost as key benchmark indices reversed direction and slipped into the red in mid-

afternoon trade as European stocks dropped after the European Central Bank warned that it will cut off

emergency funding for Cyprus's troubled banks if Cyprus doesn't seal a bailout deal by Monday, 25

March 2013. The market extended losses to hit fresh intraday low in late trade.A bout of initial

volatility was witnessed as key benchmark alternately swung between positive and negative zone. The

Sensex continued to move alternately between gains and losses in morning trade.

STOCKS TO WATCH

IDBI

IDEA CELLULAR

ITC

ICICI BANK

SCRIPS IN BAN PERIOD

PUNJLLYOD

HDIL

IVRCLINFRA

WWW.EPICRESEARCH.CO 09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Bearish

Strategy: Sell on rise

Support: 5600

Resistance: 5700

BANK NIFTY

Bank Nifty looks Bearish

Strategy: Sell on rise

Support: 11150

Resistance: 11260

460

.0

GAINERS AND LOOSERS

PREVIOUS PERFORMANCE

TYPE SCRIP B/S RESULT

CASH DLF S TARGET HIT

CASH RELIANC E CAPITAL

S TARGET HIT

FUTURE IDBI S NOT

EXECUTED

FUTURE AMBUJA S NOT

EXECUTED

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

IDFC 143.15 8275.53 136.55 6.60 4.83

Ambuja Cement

176.00 2484.49 168.90 7.10 4.20

Bank Of Baroda

676.65 983.37 651.40 25.25 3.88

Bajaj Auto

1820.65 486.27 1755.30 65.35 3.72

Jindal Steel

352.75 1699.22 341.70 11.05 3.23

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

DLF 230.95 10728.23 239.45 -8.50 -3.55

Ranbaxy Labs.

432.05 686.15 440.75 -8.70 -1.97

Tata Steel

321.85 3812.42 327.85 -6.00 -1.83

SBI 2083.95 2089.47 2119.45 -35.50 -1.67

Sun Pharma

820.50 937.37 831.30 -10.80 -1.30

6

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

IDEA CELLULAR SELL 106.80 106.30 105.80 107.30

PVR SELL 285.00 283.00 281.00 287.00

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

IDFC BUY 144.70 145.70 146.70 143.70

AURO PHARMA SELL 139.10 138.10 137.10 140.10

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.